Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model.

CONCLUSIONS: These results provide the first evidence of the potential utility of lixivaptan for the treatment of ADPKD.
PMID: 31117065 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - May 21, 2019 Category: Urology & Nephrology Authors: Wang X, Constans MM, Chebib FT, Torres VE, Pellegrini L Tags: Am J Nephrol Source Type: research